Status:
COMPLETED
Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery
Lead Sponsor:
Carl Zeiss Meditec AG
Conditions:
Senile Cataract
Eligibility:
All Genders
18+ years
Brief Summary
Subjects who had a bilateral age-related cataract surgery with the IOLs AT ELANA 841P and AT LISA tri 839MP will be contacted and invited to attend a postoperative visit more than one year after the s...
Detailed Description
The main objective of this clinical investigation is to collect data on the IOLs AT ELANA 841P and AT LISA tri 839MP in subjects who underwent bilateral cataract surgery with the use of the two differ...
Eligibility Criteria
Inclusion
- Adult patient of any gender;
- Patients who had an uncomplicated (no intra-operative complication) age-related cataract surgery
- Currently implanted with an IOL model AT ELANA 841P into the capsular bag in one eye and with the IOL model AT LISA tri 839MP into the capsular bag of the other eye.
- The postoperative visit was scheduled to be conducted more than one year after the second eye surgery.
- Given written informed consent by patient.
Exclusion
- Patients unable to meet the limitations of the protocol or likely of non-cooperation during the study
- Patient whose freedom is impaired by administrative or legal order
- Concurrent participation in another drug or device investigation that could confound the outcome of this investigation.
Key Trial Info
Start Date :
September 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 22 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06192901
Start Date
September 18 2023
End Date
September 22 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Quesada
San Salvador, El Salvador